These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 36620546)

  • 1. Overexpression of Mena is associated with tumor progression and poor prognosis in oral squamous cell carcinoma
    Na S; Cui H; Guo Z; Liang X; Sakran KA; Guo X; Li X; Xie L; Zhu Y; Qi H; Tu J
    Front Oncol; 2022; 12():1052375. PubMed ID: 36620546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification and Validation of PLOD2 as an Adverse Prognostic Biomarker for Oral Squamous Cell Carcinoma.
    Sun Y; Wang S; Zhang X; Wu Z; Li Z; Ding Z; Huang X; Chen S; Jing Y; Zhang X; Ding L; Song Y; Sun G; Ni Y
    Biomolecules; 2021 Dec; 11(12):. PubMed ID: 34944486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High ACTN1 Is Associated with Poor Prognosis, and ACTN1 Silencing Suppresses Cell Proliferation and Metastasis in Oral Squamous Cell Carcinoma.
    Xie GF; Zhao LD; Chen Q; Tang DX; Chen QY; Lu HF; Cai JR; Chen Z
    Drug Des Devel Ther; 2020; 14():1717-1727. PubMed ID: 32440097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Upregulation of XRN2 acts as an oncogene in oral squamous cell carcinoma and correlates with poor prognosis.
    Liu JC; Gao L; Li SM; Zheng JJ; Li DG; Zhi KQ; Ren WH
    Pathol Res Pract; 2021 Mar; 219():153355. PubMed ID: 33626405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long noncoding RNA MYOSLID promotes invasion and metastasis by modulating the partial epithelial-mesenchymal transition program in head and neck squamous cell carcinoma.
    Xiong HG; Li H; Xiao Y; Yang QC; Yang LL; Chen L; Bu LL; Zhang WF; Zhang JL; Sun ZJ
    J Exp Clin Cancer Res; 2019 Jun; 38(1):278. PubMed ID: 31238980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FCGBP Is a Promising Prognostic Biomarker and Correlates with Immunotherapy Efficacy in Oral Squamous Cell Carcinoma.
    Shen T; Zhang J; Wang Y; Liu B
    J Immunol Res; 2022; 2022():8443392. PubMed ID: 35733916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pituitary tumor-transforming gene 1 (PTTG1) is overexpressed in oral squamous cell carcinoma (OSCC) and promotes migration, invasion and epithelial-mesenchymal transition (EMT) in SCC15 cells.
    Zhang E; Liu S; Xu Z; Huang S; Tan X; Sun C; Lu L
    Tumour Biol; 2014 Sep; 35(9):8801-11. PubMed ID: 24879625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic and clinicopathological significance of cytocapsular tubes in oral squamous cell carcinoma.
    Wang W; Xie N; Yi C; Zhang M; Xiong G; Xu X; Hou J; Wang C
    J Oral Pathol Med; 2022 Jul; 51(6):520-528. PubMed ID: 35652154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HOXC10 promotes migration and invasion via the WNT-EMT signaling pathway in oral squamous cell carcinoma.
    Dai BW; Yang ZM; Deng P; Chen YR; He ZJ; Yang X; Zhang S; Wu HJ; Ren ZH
    J Cancer; 2019; 10(19):4540-4551. PubMed ID: 31528218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-146a promotes proliferation, invasion, and epithelial-to-mesenchymal transition in oral squamous carcinoma cells.
    Wang F; Ye LJ; Wang FJ; Liu HF; Wang XL
    Environ Toxicol; 2020 Oct; 35(10):1050-1057. PubMed ID: 32469461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High expression of TROP2 is correlated with poor prognosis of oral squamous cell carcinoma.
    Tang G; Tang Q; Jia L; Xia S; Li J; Chen Y; Li H; Ding X; Wang F; Hou D; Kuai X; Feng Z; Fan Y
    Pathol Res Pract; 2018 Oct; 214(10):1606-1612. PubMed ID: 30098828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Annexin A5 is a novel prognostic biomarker in oral squamous cell carcinoma.
    Zhou T; Zhang X; Song Y; Ding L; Huang X; Zhang L; Ye C; Yang Y; Celentano A; Hu Q; Ni Y
    J Oral Pathol Med; 2024 Sep; 53(8):538-543. PubMed ID: 38945807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of EIF5A2 Predicts Poor Prognosis in Patients with Oral Squamous Cell Carcinoma.
    Lin YM; Chen ML; Chen CL; Yeh CM; Sung WW
    Diagnostics (Basel); 2020 Jun; 10(7):. PubMed ID: 32605067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High MLL2 expression predicts poor prognosis and promotes tumor progression by inducing EMT in esophageal squamous cell carcinoma.
    Abudureheman A; Ainiwaer J; Hou Z; Niyaz M; Turghun A; Hasim A; Zhang H; Lu X; Sheyhidin I
    J Cancer Res Clin Oncol; 2018 Jun; 144(6):1025-1035. PubMed ID: 29532228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuropilin-1 promotes epithelial-to-mesenchymal transition by stimulating nuclear factor-kappa B and is associated with poor prognosis in human oral squamous cell carcinoma.
    Chu W; Song X; Yang X; Ma L; Zhu J; He M; Wang Z; Wu Y
    PLoS One; 2014; 9(7):e101931. PubMed ID: 24999732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BTC as a Novel Biomarker Contributing to EMT
    Shen T; Yang T; Yao M; Zheng Z; He M; Shao M; Li J; Fang C
    Front Genet; 2022; 13():875617. PubMed ID: 35846125
    [No Abstract]   [Full Text] [Related]  

  • 17. Decreased CSTA expression promotes lymphatic metastasis and predicts poor survival in oral squamous cell carcinoma.
    Wang Y; Wang L; Li X; Qu X; Han N; Ruan M; Zhang C
    Arch Oral Biol; 2021 Jun; 126():105116. PubMed ID: 33831734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Possible involvement of ΔNp63 downregulation in the invasion and metastasis of oral squamous cell carcinoma via induction of a mesenchymal phenotype.
    Goto Y; Kawano S; Matsubara R; Kiyosue T; Hirano M; Jinno T; Maruse Y; Toyoshima T; Kitamura R; Tanaka H; Oobu K; Nakamura S
    Clin Exp Metastasis; 2014 Mar; 31(3):293-306. PubMed ID: 24310252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of RRM2 is related to poor prognosis in oral squamous cell carcinoma.
    Wang S; Wang XL; Wu ZZ; Yang QC; Xiong HG; Xiao Y; Li H; Sun ZJ
    Oral Dis; 2021 Mar; 27(2):204-214. PubMed ID: 32640108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of E2F transcription factor 7 as a novel potential biomarker for oral squamous cell carcinoma.
    Zhou P; Xiao L; Xu X
    Head Face Med; 2021 Feb; 17(1):7. PubMed ID: 33637098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.